Free Radical, Carbonyl, and Nicotine Levels Produced by Juul Electronic Cigarettes.
Individual Clinical
Pharmacokinetics & Abuse Liability
Pharmacokinetics
Reilly (2019)
Method Validation approaches for analysis of Constituents in ENDS.
Nonclinical
Chemical
Methods
Reilly (2020)
Metabolomics-based safety evaluation of acute exposure to electronic cigarettes in mice.
Nonclinical
Safety Effects In Animals
Acute Exposure
Ren (2022)
a Randomized, Controlled Study to assess Changes in Biomarkers of Exposures among adults Who Smoke That Switch to Oral Nicotine Pouch Products Relative to Continuing Smoking or Stopping all Tobacco Use.
Individual Clinical
Biomarkers
Biomarkers Of Exposure
Rensch (2023)
Nicotine pharmacokinetics and subjective response among adult smokers using different flavors of on! nicotine pouches compared to combustible cigarettes.
Individual Clinical
Pharmacokinetics & Abuse Liability
Pharmacokinetics
Rensch (2021)
Relationship Between Spending on Electronic Cigarettes, 30-day use, and Disease Symptoms Among Current Adult Cigarette Smokers in the US
Clinical Searches Database
Repiratory Diseases
Yao et al (2017)
Preferred flavors and tobacco use patterns in adult dual users of cigarettes and ENDS.
Population Clinical
Consumer Use
Flavor Appeal
Rest (2022)
E-vapor aerosols do not compromise bone integrity relative to cigarette smoke after 6-month inhalation in an apoE-/- mouse model.
Nonclinical
Safety Effects In Animals
Repeat-dose
Reumann (2020)
Vaping patterns, nicotine dependence and reasons for vaping among american Indian dual users of cigarettes and electronic cigarettes.
Population Clinical
Consumer Use
Reasons For Use
Rhoades (2019)
Comparison of the effects of electronic cigarette vapours and tobacco smoke extracts on human neutrophils in vitro.
Nonclinical
Respiratory Toxicity
In Vitro
Richards (2023)